# Correction: Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study

**Authors:** Filipa Ladeira, Claudia Nobrega, João Cerqueira

PMC · DOI: 10.1007/s00415-025-13494-2 · 2025-11-18

## Full-text entities

- **Diseases:** multiple sclerosis (MESH:D009103)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

---
Source: https://tomesphere.com/paper/PMC12627164